<DOC>
	<DOCNO>NCT01876004</DOCNO>
	<brief_summary>Objectives : To evaluate , consider expectant management tubal ectopic pregnancy complementary use Methotrexate could provide good result . We evaluate success treatment time require titer β-hCG become negative . Methods : A double-blind randomized study , hold Department Obstetrics UNIFESP . The patient divide two group : one patient administer single intramuscular dose 50 mg/m2 Methotrexate patient prescribe Placebo intramuscularly . The monitoring do measurement β-hCG 4th 7th day . When decline beta-hCG titer &gt; 15 % interval , patient follow weekly dose β-hCG titer become negative . The criterion success β-hCG negative . The treatment failure occur surgery necessary .</brief_summary>
	<brief_title>Effectiveness Of Expectant Management In The Tubal Ectopic Pregnancy</brief_title>
	<detailed_description />
	<mesh_term>Cardiac Complexes , Premature</mesh_term>
	<mesh_term>Pregnancy , Ectopic</mesh_term>
	<mesh_term>Pregnancy , Tubal</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<criteria>Hemodynamic stability Initial βhCG &lt; 2000 mIU / mL Titers βhCG decline 48 hour treatment Adnexal mass &lt; 5.0 cm Desire future pregnancy Alive embryo Ectopic pregnancy tubal location Pregnancy unknown location</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>ectopic pregnancy</keyword>
	<keyword>methotrexate</keyword>
	<keyword>human chorionic gonadotropin beta subunit</keyword>
	<keyword>expectant management</keyword>
</DOC>